Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial.

Norgren L, Weiss N, Nikol S, Hinchliffe RJ, Lantis JC, Patel MR, Reinecke H, Ofir R, Rosen Y, Peres D, Aberman Z.

Eur J Vasc Endovasc Surg. 2019 Jan 24. pii: S1078-5884(18)30856-6. doi: 10.1016/j.ejvs.2018.11.008. [Epub ahead of print]

PMID:
30686676
2.

Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells.

Yang KC, Breitbart A, De Lange WJ, Hofsteen P, Futakuchi-Tsuchida A, Xu J, Schopf C, Razumova MV, Jiao A, Boucek R, Pabon L, Reinecke H, Kim DH, Ralphe JC, Regnier M, Murry CE.

JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740. doi: 10.1016/j.jacbts.2018.08.008. eCollection 2018 Dec.

3.

Evidence for Minimal Cardiogenic Potential of Stem Cell Antigen 1-Positive Cells in the Adult Mouse Heart.

Neidig LE, Weinberger F, Palpant NJ, Mignone J, Martinson AM, Sorensen DW, Bender I, Nemoto N, Reinecke H, Pabon L, Molkentin JD, Murry CE, van Berlo JH.

Circulation. 2018 Dec 18;138(25):2960-2962. doi: 10.1161/CIRCULATIONAHA.118.035273. No abstract available.

4.

Combining Breath Figures and Supercritical Fluids To Obtain Porous Polymer Scaffolds.

Castaño M, Martinez-Campos E, Pintado-Sierra M, García C, Reinecke H, Gallardo A, Rodriguez-Hernandez J, Elvira C.

ACS Omega. 2018 Oct 31;3(10):12593-12599. doi: 10.1021/acsomega.8b02024. Epub 2018 Oct 4.

5.

[The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary].

Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H.

Kardiol Pol. 2018;76(9):1283-1298. doi: 10.5603/KP.2018.0180. Polish.

6.

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.

Reinecke H, Jürgensmeyer S, Engelbertz C, Gerss J, Kirchhof P, Breithardt G, Bauersachs R, Wanner C.

BMJ Open. 2018 Sep 10;8(9):e022690. doi: 10.1136/bmjopen-2018-022690.

7.

Erratum: Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.

Liu YW, Chen B, Yang X, Fugate JA, Kalucki FA, Futakuchi-Tsuchida A, Couture L, Vogel KW, Astley CA, Baldessari A, Ogle J, Don CW, Steinberg ZL, Seslar SP, Tuck SA, Tsuchida H, Naumova AV, Dupras SK, Lyu MS, Lee J, Hailey DW, Reinecke H, Pabon L, Fryer BH, MacLellan WR, Thies RS, Murry CE.

Nat Biotechnol. 2018 Sep 6;36(9):899. doi: 10.1038/nbt0918-899a. No abstract available.

PMID:
30188532
8.

Delayed pacemaker requirement after transcatheter aortic valve implantation with a new-generation balloon expandable valve: Should we monitor longer?

De-Torres-Alba F, Kaleschke G, Vormbrock J, Orwat S, Radke R, Feurle M, Diller GP, Reinecke H, Baumgartner H.

Int J Cardiol. 2018 Dec 15;273:56-62. doi: 10.1016/j.ijcard.2018.07.131. Epub 2018 Jul 26.

PMID:
30104033
9.

Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014.

Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H.

Eur Heart J. 2018 Dec 1;39(45):4020-4029. doi: 10.1093/eurheartj/ehy452.

10.

Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records.

Kaier K, Oettinger V, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, von Zur Mühlen C, Bode C, Zehender M, Reinöhl J.

BMJ Open. 2018 Jul 28;8(7):e020204. doi: 10.1136/bmjopen-2017-020204.

11.

Prevention of sudden cardiac death in patients with Tetralogy of Fallot: Risk assessment and long term outcome.

Probst J, Diller GP, Reinecke H, Leitz P, Frommeyer G, Orwat S, Vormbrock J, Radke R, de Torres Alba F, Kaleschke G, Baumgartner H, Eckardt L, Wasmer K.

Int J Cardiol. 2018 Oct 15;269:91-96. doi: 10.1016/j.ijcard.2018.06.107. Epub 2018 Jun 28.

PMID:
29980366
12.

Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.

Liu YW, Chen B, Yang X, Fugate JA, Kalucki FA, Futakuchi-Tsuchida A, Couture L, Vogel KW, Astley CA, Baldessari A, Ogle J, Don CW, Steinberg ZL, Seslar SP, Tuck SA, Tsuchida H, Naumova AV, Dupras SK, Lyu MS, Lee J, Hailey DW, Reinecke H, Pabon L, Fryer BH, MacLellan WR, Thies RS, Murry CE.

Nat Biotechnol. 2018 Aug;36(7):597-605. doi: 10.1038/nbt.4162. Epub 2018 Jul 2.

13.

[Peripheral Arterial Disease - Trends in Morbidity and Mortality].

Malyar N, Freisinger E, Reinecke H.

Dtsch Med Wochenschr. 2018 Jun;143(11):e1. doi: 10.1055/a-0641-1105. Epub 2018 Jun 13. German. No abstract available.

PMID:
29898467
14.

[Field tests for the beta version of the ICD-11-MMS in Germany: background and methods].

Stausberg J, Pollex-Krüger A, Semler SC, Vogel U, Reinecke H.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Jul;61(7):836-844. doi: 10.1007/s00103-018-2751-x. German.

PMID:
29845303
15.

[Peripheral Arterial Disease - Trends in Morbidity and Mortality].

Malyar N, Freisinger E, Reinecke H.

Dtsch Med Wochenschr. 2018 Jun;143(11):766-770. doi: 10.1055/s-0044-100859. Epub 2018 May 28. German. Erratum in: Dtsch Med Wochenschr. 2018 Jun;143(11):e1.

PMID:
29807373
16.

Nationwide Routine-Data Analysis of Sex Differences in Outcome of Acute Myocardial Infarction.

Freisinger E, Sehner S, Malyar NM, Suling A, Reinecke H, Wegscheider K.

Clin Cardiol. 2018 Aug;41(8):1013-1021. doi: 10.1002/clc.22962. Epub 2018 Jun 11.

17.

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.

Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group.

Europace. 2018 Aug 1;20(8):1231-1242. doi: 10.1093/europace/euy054.

PMID:
29562331
18.

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group .

Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.

PMID:
29562325
19.

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants .

Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060. No abstract available.

20.

Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.

Ferreccio A, Mathieu J, Detraux D, Somasundaram L, Cavanaugh C, Sopher B, Fischer K, Bello T, M Hussein A, Levy S, Cook S, Sidhu SB, Artoni F, Palpant NJ, Reinecke H, Wang Y, Paddison P, Murry C, Jayadev S, Ware C, Ruohola-Baker H.

Cell Cycle. 2018;17(5):535-549. doi: 10.1080/15384101.2018.1442621. Epub 2018 Apr 5.

PMID:
29466914
21.

PCSK9 inhibition for LDL lowering and beyond - implications for patients with peripheral artery disease.

Gebauer K, Reinecke H.

Vasa. 2018 Apr;47(3):165-176. doi: 10.1024/0301-1526/a000689. Epub 2018 Feb 7. Review.

22.

Low rate of revascularization procedures and poor prognosis particularly in male patients with peripheral artery disease - A propensity score matched analysis.

Freisinger E, Malyar NM, Reinecke H, Unrath M.

Int J Cardiol. 2018 Mar 15;255:188-194. doi: 10.1016/j.ijcard.2017.12.054. Epub 2017 Dec 26.

PMID:
29329771
23.

Prevalence and impact of critical limb ischaemia on in-hospital outcome in transcatheter aortic valve implantation in Germany.

Malyar NM, Kaier K, Freisinger E, Lüders F, Kaleschke G, Baumgartner H, Frankenstein L, Reinecke H, Reinöhl J.

EuroIntervention. 2017 Dec 20;13(11):1281-1287. doi: 10.4244/EIJ-D-17-00228.

24.

Facile one-pot exfoliation and integration of 2D layered materials by dispersion in a photocurable polymer precursor.

Gallardo A, Pereyra Y, Martínez-Campos E, García C, Acitores D, Casado-Losada I, Gómez-Fatou MA, Reinecke H, Ellis G, Acevedo D, Rodríguez-Hernández J, Salavagione HJ.

Nanoscale. 2017 Aug 3;9(30):10590-10595. doi: 10.1039/c7nr03204h.

PMID:
28726951
25.

In Reply.

Kröger K, Berg C, Santosa F, Malyar N, Reinecke H.

Dtsch Arztebl Int. 2017 Jun 5;114(22-23):400. doi: 10.3238/arztebl.2017.0400. No abstract available.

26.

Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry.

Engelbertz C, Reinecke H, Breithardt G, Schmieder RE, Fobker M, Fischer D, Schmitz B, Pinnschmidt HO, Wegscheider K, Pavenstädt H, Brand E.

Int J Cardiol. 2017 Sep 15;243:65-72. doi: 10.1016/j.ijcard.2017.05.022. Epub 2017 May 7.

PMID:
28526542
27.

Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement.

Gutmann A, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Bothe W, von Zur Mühlen C, Zehender M, Reinöhl J, Bode C, Stachon P.

EuroIntervention. 2017 Sep 20;13(7):804-810. doi: 10.4244/EIJ-D-16-00927.

28.

Hydroxyl versus permethylated glycopolymers as gene carriers.

Redondo JA, Martínez-Campos E, Navarro R, Pérez-Perrino M, Reinecke H, Gallardo A, Corrales G, Fernández-Mayoralas A, Elvira C.

Eur J Pharm Biopharm. 2017 Aug;117:68-76. doi: 10.1016/j.ejpb.2017.04.001. Epub 2017 Apr 4.

PMID:
28385616
29.

Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.

Freisinger E, Malyar NM, Reinecke H, Lawall H.

Cardiovasc Diabetol. 2017 Apr 4;16(1):41. doi: 10.1186/s12933-017-0524-8.

30.

Lower Limb Amputation in Germany.

Kröger K, Berg C, Santosa F, Malyar N, Reinecke H.

Dtsch Arztebl Int. 2017 Feb 24;114(7):130-136. doi: 10.3238/arztebl.2017.0130.

31.

Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation.

Lüders F, Kaier K, Kaleschke G, Gebauer K, Meyborg M, Malyar NM, Freisinger E, Baumgartner H, Reinecke H, Reinöhl J.

Clin J Am Soc Nephrol. 2017 May 8;12(5):718-726. doi: 10.2215/CJN.10471016. Epub 2017 Mar 13.

32.

Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.

Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, Zirlik A, Bode C, Zehender M, Reinöhl J.

Int J Cardiol. 2017 May 15;235:17-21. doi: 10.1016/j.ijcard.2017.02.138. Epub 2017 Mar 2.

PMID:
28274581
33.

The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany.

Kaier K, Reinecke H, Naci H, Frankenstein L, Bode M, Vach W, Hehn P, Zirlik A, Zehender M, Reinöhl J.

Eur J Health Econ. 2018 Mar;19(2):223-228. doi: 10.1007/s10198-017-0877-7. Epub 2017 Feb 22.

PMID:
28229254
34.

Nonmigrating Equivalent Substitutes for PVC/DOP Formulations as Shown by a TG Study of PVC with Covalently Bound PEO-PPO Oligomers.

Navarro R, Gacal T, Ocakoglu M, García C, Elvira C, Gallardo A, Reinecke H.

Macromol Rapid Commun. 2017 Mar;38(6). doi: 10.1002/marc.201600734. Epub 2017 Feb 3.

PMID:
28160361
35.

Chemical and Topographical Modification of Polycarbonate Surfaces through Diffusion/Photocuring Processes of Hydrogel Precursors Based on Vinylpyrrolidone.

Gallardo A, Lujan N, Reinecke H, García C, Campo AD, Rodriguez-Hernandez J.

Langmuir. 2017 Feb 21;33(7):1614-1622. doi: 10.1021/acs.langmuir.6b04143. Epub 2017 Feb 9.

PMID:
28124914
36.

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts.

Kadota S, Pabon L, Reinecke H, Murry CE.

Stem Cell Reports. 2017 Feb 14;8(2):278-289. doi: 10.1016/j.stemcr.2016.10.009. Epub 2017 Jan 5.

37.

Adherence to medication - underutilized therapeutic potential.

Freisinger E, Reinecke H.

Vasa. 2017 Jan;46(1):69. doi: 10.1024/0301-1526/a000591. No abstract available.

38.

A Comparison of Different Algorithms for the Assessment of Cardiovascular Risk in Patients at Waiting List for Kidney Transplantation.

Reuter S, Reiermann S, Malyar V, Schütte-Nütgen K, Schmidt R, Pavenstädt H, Reinecke H, Suwelack B.

PLoS One. 2016 Oct 21;11(10):e0161927. doi: 10.1371/journal.pone.0161927. eCollection 2016.

39.

Transcatheter Aortic Valve Replacement: The New Standard in Patients With Previous Coronary Bypass Grafting?

Reinöhl J, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Zehender M, von Zur Mühlen C, Bode C, Stachon P.

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2137-2143. doi: 10.1016/j.jcin.2016.07.035.

40.

Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue.

Ruan JL, Tulloch NL, Razumova MV, Saiget M, Muskheli V, Pabon L, Reinecke H, Regnier M, Murry CE.

Circulation. 2016 Nov 15;134(20):1557-1567. Epub 2016 Oct 13.

41.

Decreasing incidence of coronary heart disease in extreme obesity (BMI≥40)-A single centre experience.

Barth S, Zacher M, Reinecke H, Hautmann MB, Kerber S, Gietzen F, Halbfass P, Schade A, Deneke T, Schieffer B, Hamm K.

Obes Res Clin Pract. 2017 Jul - Aug;11(4):435-444. doi: 10.1016/j.orcp.2016.08.007. Epub 2016 Sep 6.

PMID:
27612569
42.

Endovascular or open repair of ruptured abdominal aortic aneurysms.

Reinecke H, Donas KP.

Vasa. 2016;45(4):342. doi: 10.1024/0301-1526/a000548. No abstract available.

PMID:
27428504
43.

Determinants of decreasing major amputation rates in Germany.

Pütter C, Stausberg J, von Beckerath O, Reinecke H, Schäfer E, Kröger K.

Vasa. 2016;45(4):311-5. doi: 10.1024/0301-1526/a000543.

PMID:
27428500
44.

Aging and Outcome in Patients With Peripheral Artery Disease and Critical Limb Ischemia.

Skonetzki S, Lüders F, Engelbertz C, Malyar NM, Freisinger E, Meyborg M, Reinecke H.

J Am Med Dir Assoc. 2016 Oct 1;17(10):927-32. doi: 10.1016/j.jamda.2016.06.004. Epub 2016 Jul 15.

PMID:
27427216
45.

Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction.

Engelbertz C, Brand E, Fobker M, Fischer D, Pavenstädt H, Reinecke H.

Int J Cardiol. 2016 Oct 15;221:327-32. doi: 10.1016/j.ijcard.2016.07.058. Epub 2016 Jul 5.

PMID:
27404700
46.

Stem cell therapy in end-stage cardiovascular disease: the final nail in the coffin or still some light at the end of the tunnel?

Reinecke H, Reinecke H, Reinecke H, Reinecke H.

Vasa. 2016;45(3):260. doi: 10.1024/0301-1526/a000535. No abstract available.

PMID:
27129074
47.

Transcatheter Aortic-Valve Replacement in Clinical Practice.

Reinöhl J, Reinecke H, Zehender M.

N Engl J Med. 2016 Apr 28;374(17):1691-2. doi: 10.1056/NEJMc1601697. No abstract available.

PMID:
27119247
48.

Amputations and mortality in in-hospital treated patients with peripheral artery disease and diabetic foot syndrome.

Malyar NM, Freisinger E, Meyborg M, Lüders F, Gebauer K, Reinecke H, Lawall H.

J Diabetes Complications. 2016 Aug;30(6):1117-22. doi: 10.1016/j.jdiacomp.2016.03.033. Epub 2016 Apr 4.

PMID:
27118161
49.

The Impact of Chronic Kidney Disease on Hospitalized Patients With Peripheral Arterial Disease and Critical Limb Ischemia.

Lüders F, Fürstenberg T, Engelbertz C, Gebauer K, Meyborg M, Malyar NM, Reinecke H.

Angiology. 2017 Feb;68(2):145-150. doi: 10.1177/0003319716638797. Epub 2016 Jul 11.

PMID:
27069108
50.

Supplemental Content

Loading ...
Support Center